SCHEMBL7969377

SCHEMBL7969377

COc1ccccc1COC[C@H](N)CO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.53
TAAR1 Q96RJ0 1/20 0.45
LMNA P02545 2/20 0.44
AGTR1 P30556 1/20 0.44
CYP1A2 P05177 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HTT P42858 1/20 0.41
ABCB1 P08183 1/20 0.41
AOC3 Q16853 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PARP14 Q460N5 1/20 0.39
PARP10 Q53GL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956663 0.86 IDO1 (0.54) IDO1TAAR1LMNASMN1; SMN2GAA
SCHEMBL5878268 0.83 CYP1A2 (0.61) IDO1TAAR1LMNAAGTR1CYP1A2
SCHEMBL5595885 0.83 CYP1A2 (0.61) IDO1TAAR1LMNAAGTR1CYP1A2
SCHEMBL3952965 0.81 IDO1 (0.49) IDO1TAAR1LMNAAGTR1CYP1A2
SCHEMBL5696521 0.80 IDO1 (0.50) IDO1TAAR1LMNAAGTR1CYP1A2
SCHEMBL5694073 0.79 IDO1 (0.46) IDO1TAAR1LMNAAGTR1CYP1A2
Hydrochloric Acid SCHEMBL10411195 0.79 IDO1 (0.51) IDO1TAAR1LMNAAGTR1CYP1A2
SCHEMBL7312106 0.78 IDO1 (0.50) IDO1TAAR1LMNASMN1; SMN2GAA
SCHEMBL26654 0.77 IDO1 (0.69) IDO1TAAR1LMNASMN1; SMN2GAA
SCHEMBL17950799 0.77 LMNA (0.67) IDO1LMNAAGTR1CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274715-B1 SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY ABBOTT LABORATORIES 2001-08-14 US disclosed